Comparison of Oral Prednisolone, Budesonide and Probiotics in the Treatment of Canine Inflammatory Bowel Disease

被引:0
|
作者
Bhavani, M. Sandhya [1 ]
Kavitha, S. [1 ]
Gowri, B. [1 ]
Bhat, Abid Ali [2 ]
机构
[1] Tamil Nadu Vet & Anim Sci Univ, Madras Vet Coll, Dept Vet Clin Med, Chennai 600007, Tamil Nadu, India
[2] Univ Gondar, Dept Vet Clin Med, Coll Vet Med & Anim Sci, Gondar, Ethiopia
关键词
Budesonide; Canine; CIBDAI; Endoscopic score; IBD; Prednisolone; Probiotics; DOGS;
D O I
10.18805/IJAR.B-4424
中图分类号
S8 [畜牧、 动物医学、狩猎、蚕、蜂];
学科分类号
0905 ;
摘要
Background: Inflammatory bowel disease ( IBD) is the common cause of chronic gastrointestinal signs in dogs. The treatment possesses numerous difficulties due to the idiopathic nature of the disease. Conventional steroid therapy usually produces side effects on long term usage. Thus, there is a need for alternative therapies. When compared to human medicine, there is no published data on the use of budesonide and probiotic in the treatment of canine IBD in India. The present study was proposed to compare oral prednisolone, budesonide and probiotics in the management of canine inflammatory bowel disease. Methods: Thirty dogs with idiopathic IBD were selected and randomly grouped. They were subjected to therapy involving prednisolone, budesonide or probiotics. Clinical assessment was performed by calculation of the post treatment Clinical Inflammatory Bowel Disease Activity Index (CIBDAI) score, faecal score and endoscopy. Biochemical analysis of alkaline phosphatase and alanine transaminase were done to record side effects of steroid administration. Result: It was observed from the present study that both prednisolone and budesonide are equally effective in the management of IBD in dogs. Probiotics were found to be less effective when compared to prednisolone and budesonide in the treatment of IBD.
引用
收藏
页码:1066 / 1072
页数:7
相关论文
共 50 条
  • [1] ORAL FORMULATIONS OF BUDESONIDE: A NOVEL TREATMENT FOR INFLAMMATORY BOWEL DISEASE
    Svoboda, R. Paul
    Patel, Dhaval H.
    Olden, Kevin W.
    DRUGS OF TODAY, 2008, 44 (11) : 857 - 863
  • [2] Budesonide in the treatment of inflammatory bowel disease
    Silverman, Jason
    Otley, Anthony
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2011, 7 (04) : 419 - 428
  • [3] Budesonide treatment for inflammatory bowel disease
    Scholmerich, J
    INFLAMMATORY BOWEL DISEASES AND CHRONIC RECURRENT ABDOMINAL PAIN, 1997, 91 : 137 - 149
  • [4] Treatment with budesonide in inflammatory bowel disease
    Behrens, R
    AUTOIMMUNE DISEASES IN PEDIATRIC GASTROENTEROLOGY, 2002, 127 : 150 - 152
  • [5] A comparison of nebulized budesonide with oral prednisolone in the treatment of exacerbations of obstructive pulmonary disease
    Morice, AH
    Morris, D
    LawsonMatthew, P
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1996, 60 (06) : 675 - 678
  • [6] Probiotics in the treatment of inflammatory bowel disease
    Rioux, KP
    Fedorak, RN
    JOURNAL OF CLINICAL GASTROENTEROLOGY, 2006, 40 (03) : 260 - 263
  • [7] Probiotics for the Treatment of Inflammatory Bowel Disease
    Ganesh R. Veerappan
    John Betteridge
    Patrick E. Young
    Current Gastroenterology Reports, 2012, 14 (4) : 324 - 333
  • [8] Probiotics in the Treatment of Inflammatory Bowel Disease
    Guandalini, Stefano
    Sansotta, Naire
    PROBIOTICS AND CHILD GASTROINTESTINAL HEALTH: ADVANCES IN MICROBIOLOGY, INFECTIOUS DISEASES AND PUBLIC HEALTH, VOL 10, 2019, 1125 : 101 - 107
  • [9] Treatment of a chronic inflammatory bowel disease (Crohn's disease) with an oral glucocorticoid (budesonide)
    Hiddemann, W
    INTERNIST, 1996, 37 (02): : 195 - 196
  • [10] BUDESONIDE FOR THE TREATMENT OF INFLAMMATORY BOWEL-DISEASE
    GREENBERG, GR
    CANADIAN JOURNAL OF GASTROENTEROLOGY, 1994, 8 (06): : 369 - 372